Celyad Oncology SA
EBR:CYAD.BR
0.5 (EUR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -8.448 | -40.935 | -26.512 | -17.204 | -28.632 | -37.427 | -43.119 | -23.606 | -29.114 | -16.453 | -12.346 | -13.524 |
| Depreciation & Amortization
| 0.794 | 1.44 | 1.52 | 1.832 | 1.788 | 1.114 | 9.004 | 1.516 | 1.033 | 0.87 | 0.886 | 0.894 |
| Deferred Income Tax
| 0 | 0 | -0.531 | 1.049 | 0.085 | 0 | 0 | -0.168 | -0.006 | -0.539 | 0 | 0 |
| Stock Based Compensation
| 0.935 | 1.624 | 2.172 | 2.782 | 2.775 | 3.595 | 2.569 | 2.847 | 0.795 | 1.098 | 0.274 | 0.151 |
| Change In Working Capital
| -1.205 | -4.015 | 1.405 | -2.874 | -0.609 | 0.481 | -21.302 | -1.758 | 1.719 | 0.028 | -0.205 | -0.393 |
| Accounts Receivables
| -1.205 | 0.306 | 0 | 0 | -1.772 | -1.459 | -0.832 | -1.018 | 0.653 | -2.048 | -0.452 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 1.772 | -0.481 | 3.314 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -4.321 | 2.964 | -1.726 | 1.163 | 1.94 | -2.482 | -0.74 | 1.066 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0.306 | -1.559 | -1.148 | -1.772 | -1.459 | -17.988 | 0 | 0 | 2.076 | 0.247 | 0 |
| Other Non Cash Items
| -7.278 | 13.876 | -4.697 | -13.25 | -3.609 | 4.988 | 3.3 | -3.523 | -1.73 | -2.418 | 0.753 | 4.536 |
| Operating Cash Flow
| -15.202 | -28.01 | -26.643 | -27.665 | -28.202 | -27.249 | -49.548 | -24.692 | -27.303 | -17.414 | -10.638 | -8.337 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.899 | -0.123 | -0.393 | -0.319 | -0.622 | -1.765 | -0.858 | -1.782 | -0.838 | -0.64 | -0.531 | -0.657 |
| Acquisitions Net
| 0 | 6 | 0 | 0.235 | 0 | 0.932 | -5.107 | -1.56 | -5.186 | -1.5 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -0.476 | 0 | -26.561 | -10.749 | -34.23 | -5 | 0.372 | -3 | 0 |
| Sales Maturities Of Investments
| 0 | 1.09 | 0 | 0.241 | 9.379 | 28.859 | 34.326 | 7.338 | 0.333 | 0.372 | 0 | 0 |
| Other Investing Activites
| 1.306 | 0.235 | 0.267 | 0.476 | 0.23 | -0.858 | 5.108 | 0.077 | -4.694 | -0.372 | -3.459 | 0 |
| Investing Cash Flow
| 0.407 | 7.202 | -0.126 | 0.157 | 8.987 | 0.607 | 22.72 | -30.157 | -10.691 | -1.768 | -3.531 | -0.657 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.145 | -0.896 | -1.136 | -1.447 | -1.487 | 0.201 | -0.034 | 0.766 | 0.263 | 0.306 | 0.087 | 6.737 |
| Common Stock Issued
| 9.49 | 0 | 36.568 | 0 | 16.448 | 43.011 | 0.625 | 0 | 109.154 | 25.305 | 30.623 | 0 |
| Common Stock Repurchased
| 0 | -0.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 9.5 | 4.137 | 40.657 | 6.843 | 19.763 | 0.716 | 0.639 | 2.265 | 1.118 | 2.146 | 0.873 | 2.15 |
| Financing Cash Flow
| 9.355 | 3.241 | 39.521 | 5.396 | 18.276 | 43.928 | 0.605 | 3.031 | 110.535 | 27.757 | 31.583 | 8.887 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.001 | -0.006 | 0.032 | 0.008 | -0.265 | 0.003 | 1.12 | 0.001 | 0.001 | 0 | 0 | 0 |
| Net Change In Cash
| -5.441 | -17.573 | 12.784 | -22.104 | -1.204 | 17.289 | -25.104 | -51.817 | 72.542 | 8.575 | 17.413 | -0.106 |
| Cash At End Of Period
| 7.004 | 12.445 | 30.018 | 17.234 | 39.338 | 40.542 | 23.253 | 48.357 | 100.175 | 27.633 | 19.058 | 1.645 |